Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ-Reference-Cited by-同舟云学术

Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ

Published:2018-04 Issue: Volume:38 Page:120-124
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Masannat Yazan A.,Husain Ehab,Roylance Rebecca,Heys Steven D.,Carder Pauline J,Ali Hiam,Maurice Yasmine,Pinder Sarah E.,Sawyer Elinor,Shaaban Abeer M.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference31 articles.

1. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases;Sneige;Mod Pathol,2002

2. Neoplastic diseases;JNdsePWS,1919

3. Lobular carcinoma in situ: a rare form of mammary cancer;Foote;Am J Pathol,1941

4. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy;Rosen;Cancer,1981

5. Lobular carcinoma in situ: observation without surgery as an appropriate therapy;Carson;Ann Surg Oncol,1994

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Challenges of Lobular Carcinomas from a Surgeon’s Point of View;Clinical Breast Cancer;2024-06

2. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study;Modern Pathology;2024-04

3. Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants;Breast Cancer Research and Treatment;2024-03-12

4. Upgrade Rate and Long-term Outcomes of Lobular Neoplasia;Current Breast Cancer Reports;2024-01-31

5. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO;European Journal of Surgical Oncology;2024-01